❖ India has launched the first indigenous antibiotic "Nafithromycin" for resistant infections.

❖ It has been developed with the support of "Biotechnology Industry Research Assistance Council" (BIRAC).

❖ This has been brought to the market under the trade name "Miqnaf" by pharma company "Wolkardt".

❖ Nafithromycin marks a historic breakthrough as the first new antibiotic in its class to be developed globally in over 30 years.